| Golden Living Center-richmond | |
| 1042 Oak Dr, Richmond, Indiana 47374 | |
| (765) 966-7788 | |
| Name | Golden Living Center-richmond |
|---|---|
| Location | 1042 Oak Dr, Richmond, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 122 |
| Occupancy Rate | 41.39% |
| Medicare ID (CCN) | 155157 |
| Legal Business Name | Hendricks County Hospital |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1508812454 |
| Organization Name | HENDRICKS COUNTY HOSPITAL |
| Doing Business As | BRICKYARD HEALTHCARE - RICHMOND CARE CENTER |
| Address | 1042 Oak Dr, Richmond, IN 47374 |
| Phone Number | 765-996-7788 |
News Archive
More than half of child deaths worldwide stem from preventable causes, such as adverse effects from malnutrition.
A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.
A team of University of Michigan scientists has found that suppressing a newly discovered gene lengthens the lifespan of roundworms. Scientists who study aging have long known that significantly restricting food intake makes animals live longer. But the goal is to find less drastic ways to achieve the same effect in humans someday. The U-M results offer promising early evidence that scientists may succeed at finding targets for drugs that someday could allow people to live longer, healthier lives.
Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the company's dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukemia.
› Verified 5 days ago
| NPI Number | 1558805739 |
| Organization Name | DYCORA TRANSITIONAL HEALTH - RICHMOND LLC |
| Address | 1042 Oak Dr, Richmond, IN 47374 |
| Phone Number | 765-966-7788 |
News Archive
More than half of child deaths worldwide stem from preventable causes, such as adverse effects from malnutrition.
A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.
A team of University of Michigan scientists has found that suppressing a newly discovered gene lengthens the lifespan of roundworms. Scientists who study aging have long known that significantly restricting food intake makes animals live longer. But the goal is to find less drastic ways to achieve the same effect in humans someday. The U-M results offer promising early evidence that scientists may succeed at finding targets for drugs that someday could allow people to live longer, healthier lives.
Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the company's dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukemia.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
More than half of child deaths worldwide stem from preventable causes, such as adverse effects from malnutrition.
A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.
A team of University of Michigan scientists has found that suppressing a newly discovered gene lengthens the lifespan of roundworms. Scientists who study aging have long known that significantly restricting food intake makes animals live longer. But the goal is to find less drastic ways to achieve the same effect in humans someday. The U-M results offer promising early evidence that scientists may succeed at finding targets for drugs that someday could allow people to live longer, healthier lives.
Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the company's dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukemia.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 26.49 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.76 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.56 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.61 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 28.75 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.43 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 91.75 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.78 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 31.48 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.91 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.71 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.12 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.98 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 95.39 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 44.74 | 82.93 |
News Archive
More than half of child deaths worldwide stem from preventable causes, such as adverse effects from malnutrition.
A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.
A team of University of Michigan scientists has found that suppressing a newly discovered gene lengthens the lifespan of roundworms. Scientists who study aging have long known that significantly restricting food intake makes animals live longer. But the goal is to find less drastic ways to achieve the same effect in humans someday. The U-M results offer promising early evidence that scientists may succeed at finding targets for drugs that someday could allow people to live longer, healthier lives.
Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the company's dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukemia.
› Verified 5 days ago
Golden Living Center-golden Rule Location: 2330 Straight Line Pike, Richmond, Indiana 47374 Phone: (765) 966-7681 | |
Arbor Trace Health & Living Community Location: 3701 Hodgin Rd, Richmond, Indiana 47374 Phone: (765) 939-3701 | |